"Future investigations are warranted to disentangle the relative
contribution of antipsychotic medications, maternal mental illness,
concomitant (associated) medications and the broader psychosocial
context in the developmental trajectory of high-risk infants.
Pending such studies, these data support an additional level of
clinical scrutiny in medication selection, treatment planning and
risk/benefit discussions for women with illnesses who may warrant
antipsychotic pharmacotherapy during gestation."
http://www.medicalnewstoday.com/articles/243798.php
Powered by LSoft's LISTSERV(R) list management software